TV-45070

Drug Teva Pharmaceuticals USA, Inc.
Total Payments
$1.3M
Transactions
263
Doctors
3
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $1.3M 263 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.3M 263 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
TV-45070-CNS-20013 Teva Pharmaceuticals USA, Inc. $1.3M 3

Top Doctors Receiving Payments for TV-45070

Doctor Specialty Location Total Records
Unknown — Sacramento, CA $1.2M 254
, D.O Family Medicine Levittown, PA $15,376 5
, MD Internal Medicine Rapid City, SD $5,158 3
, D.O Internal Medicine North Massapequa, NY $1,500 1

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $1.3M
  • Total Doctors 3
  • Transactions 263

About TV-45070

TV-45070 is a drug associated with $1.3M in payments to 3 healthcare providers, recorded across 263 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..

Payment data is available from 2017 to 2017. In 2017, $1.3M was paid across 263 transactions to 3 doctors.

The most common payment nature for TV-45070 is "Unspecified" ($1.3M, 100.0% of total).

TV-45070 is associated with 1 research study, including "TV-45070-CNS-20013" ($1.3M).